TY - STD TI - Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 1 May 2019. UR - https://www.who.int/news-room/fact-sheets/detail/cancer ID - ref1 ER - TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA A Cancer J Clin. VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Adhami, V. M. AU - Malik, A. AU - Zaman, N. AU - Sarfaraz, S. AU - Siddiqui, I. A. AU - Syed, D. N. AU - Afaq, F. AU - Pasha, F. S. AU - Saleem, M. AU - Mukhtar, H. PY - 2007 DA - 2007// TI - Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2269 DO - 10.1158/1078-0432.CCR-06-2269 ID - Adhami2007 ER - TY - JOUR AU - Albain, K. S. AU - Nag, S. M. AU - Calderillo-Ruiz, G. AU - Jordaan, J. P. AU - Llombart, A. C. AU - Pluzanska, A. AU - Rolski, J. AU - Melemed, A. S. AU - Reyes-Vidal, J. M. AU - Sekhon, J. S. PY - 2008 DA - 2008// TI - Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.11.9362 DO - 10.1200/JCO.2007.11.9362 ID - Albain2008 ER - TY - JOUR AU - Mokhtari, R. B. AU - Kumar, S. AU - Islam, S. S. AU - Yazdanpanah, M. AU - Adeli, K. AU - Cutz, E. AU - Yeger, H. PY - 2013 DA - 2013// TI - Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-378 DO - 10.1186/1471-2407-13-378 ID - Mokhtari2013 ER - TY - STD TI - Guidance on the use of paclitaxel in the treatment of ovarian cancer. https://www.nice.org.uk/guidance/ta55. Accessed 1 May 2019. UR - https://www.nice.org.uk/guidance/ta55 ID - ref6 ER - TY - JOUR AU - Stordal, B. AU - Davey, M. PY - 2007 DA - 2007// TI - Understanding cisplatin resistance using cellular models JO - IUBMB Life VL - 59 UR - https://doi.org/10.1080/15216540701636287 DO - 10.1080/15216540701636287 ID - Stordal2007 ER - TY - JOUR AU - Jordan, M. A. AU - Wilson, L. PY - 2004 DA - 2004// TI - Microtubules as a target for anticancer drugs JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1317 DO - 10.1038/nrc1317 ID - Jordan2004 ER - TY - JOUR AU - Ozols, R. F. AU - Bundy, B. N. AU - Greer, B. E. AU - Fowler, J. M. AU - Clarke-Pearson, D. AU - Burger, R. A. AU - Mannel, R. S. AU - DeGeest, K. AU - Hartenbach, E. M. AU - Baergen, R. PY - 2003 DA - 2003// TI - Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.02.153 DO - 10.1200/JCO.2003.02.153 ID - Ozols2003 ER - TY - JOUR AU - Stewart, D. J. PY - 2007 DA - 2007// TI - Mechanisms of resistance to cisplatin and carboplatin JO - Crit Rev Oncol/Hematol VL - 63 UR - https://doi.org/10.1016/j.critrevonc.2007.02.001 DO - 10.1016/j.critrevonc.2007.02.001 ID - Stewart2007 ER - TY - JOUR AU - Frazier, A. L. AU - Stoneham, S. AU - Rodriguez-Galindo, C. AU - Dang, H. AU - Xia, C. AU - Olson, T. A. AU - Murray, M. J. AU - Amatruda, J. F. AU - Shaikh, F. AU - Pashankar, F. PY - 2018 DA - 2018// TI - Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: a report of the Malignant Germ Cell International Consortium JO - Eur J Cancer VL - 98 UR - https://doi.org/10.1016/j.ejca.2018.03.004 DO - 10.1016/j.ejca.2018.03.004 ID - Frazier2018 ER - TY - JOUR AU - Jiang, S. AU - Pan, A. W. AU - Lin, T. Y. AU - Zhang, H. AU - Malfatti, M. AU - Turteltaub, K. AU - Henderson, P. T. AU - Pan, C. X. PY - 2015 DA - 2015// TI - Paclitaxel enhances carboplatin-dna adduct formation and cytotoxicity JO - Chem Res Toxicol VL - 28 UR - https://doi.org/10.1021/acs.chemrestox.5b00422 DO - 10.1021/acs.chemrestox.5b00422 ID - Jiang2015 ER - TY - JOUR AU - Bhattacharya, S. AU - Muhammad, N. AU - Steele, R. AU - Kornbluth, J. AU - Ray, R. B. PY - 2017 DA - 2017// TI - Bitter Melon enhances natural killer-mediated toxicity against head and neck cancer cells JO - Cancer Prev Res VL - 10 UR - https://doi.org/10.1158/1940-6207.CAPR-17-0046 DO - 10.1158/1940-6207.CAPR-17-0046 ID - Bhattacharya2017 ER - TY - JOUR AU - Wright, G. D. PY - 2017 DA - 2017// TI - Opportunities for natural products in 21(st) century antibiotic discovery JO - Nat Prod Rep VL - 34 UR - https://doi.org/10.1039/C7NP00019G DO - 10.1039/C7NP00019G ID - Wright2017 ER - TY - JOUR AU - Yao, H. AU - Liu, J. AU - Xu, S. AU - Zhu, Z. AU - Xu, J. PY - 2017 DA - 2017// TI - The structural modification of natural products for novel drug discovery JO - Expert Opin Drug Discov VL - 12 UR - https://doi.org/10.1080/17460441.2016.1272757 DO - 10.1080/17460441.2016.1272757 ID - Yao2017 ER - TY - JOUR AU - Muhammad, N. AU - Steele, R. AU - Isbell, T. S. AU - Philips, N. AU - Ray, R. B. PY - 2017 DA - 2017// TI - Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.19887 DO - 10.18632/oncotarget.19887 ID - Muhammad2017 ER - TY - JOUR AU - Bhattacharya, S. AU - Muhammad, N. AU - Steele, R. AU - Peng, G. AU - Ray, R. B. PY - 2016 DA - 2016// TI - Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.8898 DO - 10.18632/oncotarget.8898 ID - Bhattacharya2016 ER - TY - JOUR AU - Sun, J. AU - Chu, Y. F. AU - Wu, X. AU - Liu, R. H. PY - 2002 DA - 2002// TI - Antioxidant and antiproliferative activities of common fruits JO - J Agric Food Chem VL - 50 UR - https://doi.org/10.1021/jf0207530 DO - 10.1021/jf0207530 ID - Sun2002 ER - TY - JOUR AU - Dai, J. AU - Mumper, R. J. PY - 2010 DA - 2010// TI - Plant phenolics: extraction, analysis and their antioxidant and anticancer properties JO - Molecules VL - 15 UR - https://doi.org/10.3390/molecules15107313 DO - 10.3390/molecules15107313 ID - Dai2010 ER - TY - JOUR AU - De, A. AU - De, A. AU - Papasian, C. AU - Hentges, S. AU - Banerjee, S. AU - Haque, I. AU - Banerjee, S. K. PY - 2013 DA - 2013// TI - Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0072748 DO - 10.1371/journal.pone.0072748 ID - De2013 ER - TY - JOUR AU - Sourani, Z. M. AU - Pourgheysari, B. P. AU - Beshkar, P. M. AU - Shirzad, H. P. AU - Shirzad, M. M. PY - 2016 DA - 2016// TI - Gallic Acid inhibits proliferation and induces apoptosis in lymphoblastic leukemia cell line (C121) JO - Iran J Med Sci VL - 41 ID - Sourani2016 ER - TY - JOUR AU - Yoshino, M. AU - Haneda, M. AU - Naruse, M. AU - Htay, H. H. AU - Iwata, S. AU - Tsubouchi, R. AU - Murakami, K. PY - 2002 DA - 2002// TI - Prooxidant action of gallic acid compounds: copper-dependent strand breaks and the formation of 8-hydroxy-2′-deoxyguanosine in DNA JO - Toxicol in Vitro VL - 16 UR - https://doi.org/10.1016/S0887-2333(02)00061-9 DO - 10.1016/S0887-2333(02)00061-9 ID - Yoshino2002 ER - TY - JOUR AU - Mejia, E. G. AU - Ramirez-Mares, M. V. AU - Puangpraphant, S. PY - 2009 DA - 2009// TI - Bioactive components of tea: cancer, inflammation and behavior JO - Brain Behav Immun VL - 23 UR - https://doi.org/10.1016/j.bbi.2009.02.013 DO - 10.1016/j.bbi.2009.02.013 ID - Mejia2009 ER - TY - JOUR AU - He, Z. AU - Li, B. AU - Rankin, G. O. AU - Rojanasakul, Y. AU - Chen, Y. C. PY - 2015 DA - 2015// TI - Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells JO - Oncol Lett VL - 9 UR - https://doi.org/10.3892/ol.2014.2818 DO - 10.3892/ol.2014.2818 ID - He2015 ER - TY - JOUR AU - Han, Y. H. AU - Park, W. H. PY - 2009 DA - 2009// TI - Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis JO - Lung Cancer VL - 65 UR - https://doi.org/10.1016/j.lungcan.2008.11.005 DO - 10.1016/j.lungcan.2008.11.005 ID - Han2009 ER - TY - JOUR AU - Burnette, W. PY - 1981 DA - 1981// TI - “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A JO - Anal Biochem VL - 112 UR - https://doi.org/10.1016/0003-2697(81)90281-5 DO - 10.1016/0003-2697(81)90281-5 ID - Burnette1981 ER - TY - BOOK AU - Sambrook, J. AU - Fritsch, E. F. AU - Maniatis, T. PY - 1989 DA - 1989// TI - Molecular cloning: a laboratory manual PB - Cold Spring Harbor CY - Cold Spring Harbor Laboratory ID - Sambrook1989 ER - TY - JOUR AU - You, B. R. AU - Moon, H. J. AU - Han, Y. H. AU - Park, W. H. PY - 2010 DA - 2010// TI - Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis JO - Food Chem Toxicol VL - 48 UR - https://doi.org/10.1016/j.fct.2010.02.034 DO - 10.1016/j.fct.2010.02.034 ID - You2010 ER - TY - JOUR AU - You, B. R. AU - Kim, S. Z. AU - Kim, S. H. AU - Park, W. H. PY - 2011 DA - 2011// TI - Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion JO - Mol Cell Biochem VL - 357 UR - https://doi.org/10.1007/s11010-011-0900-8 DO - 10.1007/s11010-011-0900-8 ID - You2011 ER - TY - JOUR AU - You, B. R. AU - Park, W. H. PY - 2010 DA - 2010// TI - Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase JO - Toxicol in Vitro VL - 24 UR - https://doi.org/10.1016/j.tiv.2010.04.009 DO - 10.1016/j.tiv.2010.04.009 ID - You2010 ER - TY - JOUR AU - Park, W. H. PY - 2017 DA - 2017// TI - Gallic acid induces HeLa cell death via increasing GSH depletion rather than ROS levels JO - Oncol Rep VL - 37 UR - https://doi.org/10.3892/or.2016.5335 DO - 10.3892/or.2016.5335 ID - Park2017 ER - TY - JOUR AU - Dorniani, D. AU - Saifullah, B. AU - Barahuie, F. AU - Arulselvan, P. AU - Hussein, M. Z. AU - Fakurazi, S. AU - Twyman, L. J. PY - 2016 DA - 2016// TI - Graphene oxide-Gallic Acid nanodelivery system for cancer therapy JO - Nanoscale Res Lett VL - 11 UR - https://doi.org/10.1186/s11671-016-1712-2 DO - 10.1186/s11671-016-1712-2 ID - Dorniani2016 ER - TY - JOUR AU - Mosmann, T. PY - 1983 DA - 1983// TI - Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays JO - J Immunol Methods VL - 65 UR - https://doi.org/10.1016/0022-1759(83)90303-4 DO - 10.1016/0022-1759(83)90303-4 ID - Mosmann1983 ER - TY - JOUR AU - Barltrop, J. A. AU - Owen, T. C. AU - Cory, A. H. AU - Cory, J. G. PY - 1991 DA - 1991// TI - 5-(3-Carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators JO - Bioorg Med Chem Lett. VL - 1 UR - https://doi.org/10.1016/S0960-894X(01)81162-8 DO - 10.1016/S0960-894X(01)81162-8 ID - Barltrop1991 ER - TY - JOUR AU - Ishiyama, M. AU - Miyazono, Y. AU - Sasamoto, K. AU - Ohkura, Y. AU - Ueno, K. PY - 1997 DA - 1997// TI - A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability JO - Talanta VL - 44 UR - https://doi.org/10.1016/S0039-9140(97)00017-9 DO - 10.1016/S0039-9140(97)00017-9 ID - Ishiyama1997 ER - TY - JOUR AU - He, Y. AU - Zhu, Q. AU - Chen, M. AU - Huang, Q. AU - Wang, W. AU - Li, Q. AU - Huang, Y. AU - Di, W. PY - 2016 DA - 2016// TI - The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer JO - Oncotarget VL - 7 ID - He2016 ER - TY - JOUR AU - Chen, Y. J. AU - Lin, K. N. AU - Jhang, L. M. AU - Huang, C. H. AU - Lee, Y. C. AU - Chang, L. S. PY - 2016 DA - 2016// TI - Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells JO - Chem Biol Interact VL - 252 UR - https://doi.org/10.1016/j.cbi.2016.04.025 DO - 10.1016/j.cbi.2016.04.025 ID - Chen2016 ER - TY - JOUR AU - Zhao, B. AU - Hu, M. PY - 2013 DA - 2013// TI - Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells JO - Oncol Lett VL - 6 UR - https://doi.org/10.3892/ol.2013.1632 DO - 10.3892/ol.2013.1632 ID - Zhao2013 ER - TY - JOUR AU - Verma, S. AU - Singh, A. AU - Mishra, A. PY - 2013 DA - 2013// TI - Gallic acid: molecular rival of cancer JO - Environ Toxicol Pharmacol VL - 35 UR - https://doi.org/10.1016/j.etap.2013.02.011 DO - 10.1016/j.etap.2013.02.011 ID - Verma2013 ER - TY - JOUR AU - Ou, T. T. AU - Wang, C. J. AU - Lee, Y. S. AU - Wu, C. H. AU - Lee, H. J. PY - 2010 DA - 2010// TI - Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3beta release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells JO - Mol Nutr Food Res VL - 54 UR - https://doi.org/10.1002/mnfr.201000096 DO - 10.1002/mnfr.201000096 ID - Ou2010 ER - TY - JOUR AU - Agarwal, C. AU - Singh, R. P. AU - Dhanalakshmi, S. AU - Tyagi, A. K. AU - Tecklenburg, M. AU - Sclafani, R. A. AU - Agarwal, R. PY - 2003 DA - 2003// TI - Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1207158 DO - 10.1038/sj.onc.1207158 ID - Agarwal2003 ER - TY - JOUR AU - Taylor, W. R. AU - Stark, G. R. PY - 2001 DA - 2001// TI - Regulation of the G2/M transition by p53 JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204252 DO - 10.1038/sj.onc.1204252 ID - Taylor2001 ER - TY - JOUR AU - Martin, P. AU - Pognonec, P. PY - 2010 DA - 2010// TI - ERK and cell death: cadmium toxicity, sustained ERK activation and cell death JO - FEBS J VL - 277 UR - https://doi.org/10.1111/j.1742-4658.2009.07369.x DO - 10.1111/j.1742-4658.2009.07369.x ID - Martin2010 ER - TY - JOUR AU - Tsujimoto, Y. PY - 2003 DA - 2003// TI - Cell death regulation by the Bcl-2 protein family in the mitochondria JO - J Cell Physiol VL - 195 UR - https://doi.org/10.1002/jcp.10254 DO - 10.1002/jcp.10254 ID - Tsujimoto2003 ER - TY - JOUR AU - Fridman, J. S. AU - Lowe, S. W. PY - 2003 DA - 2003// TI - Control of apoptosis by p53 JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1207116 DO - 10.1038/sj.onc.1207116 ID - Fridman2003 ER - TY - JOUR AU - Flatt, P. M. AU - Tang, L. J. AU - Scatena, C. D. AU - Szak, S. T. AU - Pietenpol, J. A. PY - 2000 DA - 2000// TI - p53 regulation of G(2) checkpoint is retinoblastoma protein dependent JO - Mol Cell Biol VL - 20 UR - https://doi.org/10.1128/MCB.20.12.4210-4223.2000 DO - 10.1128/MCB.20.12.4210-4223.2000 ID - Flatt2000 ER - TY - JOUR AU - Wang, R. AU - Ma, L. AU - Weng, D. AU - Yao, J. AU - Liu, X. AU - Jin, F. PY - 2016 DA - 2016// TI - Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway JO - Oncol Rep VL - 35 UR - https://doi.org/10.3892/or.2016.4690 DO - 10.3892/or.2016.4690 ID - Wang2016 ER - TY - JOUR AU - Thornberry, N. A. AU - Lazebnik, Y. PY - 1998 DA - 1998// TI - Caspases: enemies within JO - Science VL - 281 UR - https://doi.org/10.1126/science.281.5381.1312 DO - 10.1126/science.281.5381.1312 ID - Thornberry1998 ER - TY - JOUR AU - Sanchez-Carranza, J. N. AU - Diaz, J. F. AU - Redondo-Horcajo, M. AU - Barasoain, I. AU - Alvarez, L. AU - Lastres, P. AU - Romero-Estrada, A. AU - Aller, P. AU - Gonzalez-Maya, L. PY - 2018 DA - 2018// TI - Gallic acid sensitizes paclitaxel-resistant human ovarian carcinoma cells through an increase in reactive oxygen species and subsequent downregulation of ERK activation JO - Oncol Rep VL - 39 ID - Sanchez-Carranza2018 ER - TY - JOUR AU - Johnson, G. L. AU - Lapadat, R. PY - 2002 DA - 2002// TI - Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases JO - Science VL - 298 UR - https://doi.org/10.1126/science.1072682 DO - 10.1126/science.1072682 ID - Johnson2002 ER -